Celgene

1 statements across 1 episodes · 1 bullish · 0 bearish · 1 people on the record · first statement Feb 28, 2019 by Nate Chang · said 4 times in 1 episodes since 2019 · across every show →

Mentions by year

brought up most by Nate Chang (3), Frank Chen (1)

tap a year for its mentions
0021412019episodesmentions
0112019episodes it came up in
0020.5412019episodesmentions per episode
2019 4 mentions in 1 episode

every mention, scene by scene, with the transcript →

Everything said about Celgene, oldest first

Feb 28, 2019 positive
Assertion Not checkable as stated
Nate Chang: Celgene set the standard for early-stage biotech licensing deals
“Celgene had a great playbook. They were very active in looking at earlier stage companies in terms of licensing, licensing with equity or also licensing with the option of buy. They had all those structures laid out for a lot of their early stage investments.”
Nate Chang Feb 28, 2019 ▶ 10:32 What’s with All the Bio M&A in 2019?: A Quick Take
Made with StarZero

Turn any episode into a week of clips.

This entire site, over 1,000 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.